Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Endocrine 1

Conditions

Brain Neoplasms 41Carcinoma, Non-Small-Cell Lung 35Neoplasm Metastasis 32Pancreatic Neoplasms 30Prostatic Neoplasms 24Lung Neoplasms 21Carcinoma, Hepatocellular 21Melanoma 16Breast Neoplasms 12Liver Neoplasms 10Glioblastoma 10Squamous Cell Carcinoma of Head and Neck 8Carcinoma, Renal Cell 8Neoplasms 7Head and Neck Neoplasms 7Kidney Neoplasms 6Gliosarcoma 6Sarcoma 5Glioma 5Central Nervous System Neoplasms 5Uterine Cervical Neoplasms 4Salivary Gland Neoplasms 4Colorectal Neoplasms 4Vulvar Neoplasms 3Vaginal Neoplasms 3Recurrence 3Radiation Injuries 3Pain 3Ovarian Neoplasms 3Fallopian Tube Neoplasms 3

Interventions

Paclitaxel 4pembrolizumab 2pazopanib 2Trastuzumab 2Sorafenib 2Radiotherapy, Intensity-Modulated 2Radiotherapy 2Gefitinib 2Doxorubicin 2Cisplatin 2tumor necrosis factor-alpha, CNGRC fusion protein, human 1tremelimumab 1trametinib 1tipifarnib 1spartalizumab 1sargramostim 1sapanisertib 1mercaptoundecahydrododecaborate 1lenvatinib 1fosbretabulin 1efatutazone 1durvalumab 1dabrafenib 1crolibulin 1cabozantinib 1atezolizumab 1aldesleukin 1abemaciclib 1Taxes 1Tamoxifen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Thyroid Carcinoma, Anaplastic × Radiosurgery × Clear all
NCT03122496 2022-06-08

Immunotherapy and Stereotactic Body Radiotherapy (SBRT) for Metastatic Anaplastic Thyroid Cancer

Memorial Sloan Kettering Cancer Center

Phase 1 Completed
13 enrolled
EndocrineHead & Neck

Thyroid Carcinoma, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡